The 340B drug pricing plan is meant to help low-income patients. It needs better oversight in this state.

Reforming the federal 340B Drug Pricing Program is a fast and efficient way to reduce drug costs and protect patients. These days, some 340B hospitals are taking advantage of low-income and uninsured ...

Health Affairs' Rob Lott interviews Sayeh Nikpay of the University of Minnesota about her recent paper exploring how The Medicaid Drug Rebate Program and the 340B Program interact in ways that can ...

Ryan Long, the co-author of a recent USC Schaeffer Center white paper on the 340B Drug Pricing Program, argues that meaningful reform requires shifting to a direct subsidy model based on need. The ...

The federal 340B Drug Pricing Program ("340B Program") was created by Congress in 1992 through an amendment to the Public Health Service Act. [i] The program, which is administered by the Health ...

Hospitals that serve a high volume of low-income and uninsured patients rely on Disproportionate Share Hospital (DSH) funding to maintain financial stability. A hospital’s DSH percentage is critical ...

The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all ...

The 340B Drug Pricing Program was created to help low-income patients access medications at reduced costs. Ryan Augsburger argues that expanding the program could increase costs for employers and ...

On January 15, 2026, President Trump released a one-page health policy framework. Among other things, the document includes calls for ...

For many Ohio businesses, the word “expansion” typically signals growth, opportunity and new jobs. However, over time, the program has grown far beyond its original scope. Large hospital systems, ...